Start
Amniotics
About us
Corporate Governance
General Meeting
Nomination Committee
Board of Directors
Management
Auditors
Articles of association
Donors
R&D
Pipeline
Diseases
Stem Cell Therapies
Publications
HyperTargIPS-NK
Participants
News
CDMO services
Partnering
Investors
Financial Reports
Företrädesemission Q4 2023
Preferential Rights Issue Q1 2023
IPO 2021
Financial calendar
Key financials
Share information
Events
Analyst coverage
IR contacts
Magle Chemoswed bid
Merger
Media
All Press & News
Press Releases
News
Media gallery
Career
Open positions
Menu
Menu
Start
Amniotics
▼
About us
Corporate Governance
▼
General Meeting
Nomination Committee
Board of Directors
Management
Auditors
Articles of association
Donors
R&D
▼
Pipeline
Diseases
Stem Cell Therapies
Publications
HyperTargIPS-NK
▼
Participants
News
CDMO services
Partnering
Investors
▼
Financial Reports
Företrädesemission Q4 2023
Preferential Rights Issue Q1 2023
IPO 2021
Financial calendar
Key financials
Share information
Events
Analyst coverage
IR contacts
Magle Chemoswed bid
Merger
Media
▼
All Press & News
Press Releases
News
Media gallery
Career
▼
Open positions
Media
Media
All Press & News
Press Releases
News
Media gallery
Amniotics is featured on TV4 for their novel source of MSCs to treat COVID-19
News
July 3, 2020
Article
« Older post
Newer post »
Upcoming events
Read more
Subscribe
